RHYTHM PHARMACEUTICALS, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $1.26 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $1.26M.
- RHYTHM PHARMACEUTICALS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $8.46M.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month |
|---|---|---|
| 2026-06-30 | $1.26M 10-Q · filed 2026-08-04 | $9.71M derived: sum of 2 quarters · filed 2026-08-04 |
| 2026-03-31 | $8.46M 10-Q · filed 2026-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |